Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | 1₹18.1 LAccepted-Finance | 1 | Accepted-Finance lowest | |
| 2 | 2₹20.2 L+₹2.1 L (11.4%)Rejected-Finance | 2 | Rejected-Finance 2nd lowest | |
| 3 | Not Admitted-Fee/PreQual/Technical | - | Not Admitted-Fee/PreQual/Technical Not Complied with technical specification |
Tender Value
₹25 L
EMD Value
₹25,500
Closing Date
4 Jul 2023, 10:00 amClosed
CMS DISTRICT HOSPITAL BUDAUN
CMS OFFICE DISTRICT HOSPITAL BUDAUN
DRUG CONSUMABLE
2023_DGMH_809313_2
2023-24/1156 DT 03-06-2023
Open Tender
Miscellaneous
Percentage
365 days
BUDAUN
Please refer Tender documents.
2 documents required · 2 mandatory
₹4,425
CMS DH
₹25,500
Yes
19 Jul 2023
27 Jun 2023
4 Jul 2023
27 Jun 2023
4 Jul 2023
27 Jun 2023
eProcurement System Government of Uttar Pradesh Created By: Kaptan Singh Created Date/Time: 07-Jul-2023 04:36 PM Tender Title: DRUG CONSUMABLE Tender ID: 2023_DGMH_809313_2
Tender Inviting Authority: CMS DISTRICT HOSPITAL BUDAUN
Name of Work: DRUG AND DRUG CONSUMABLE
SCHEDULE OF WORK / ITEM(S)
Sl.No Bidder Name Estimated Rate Quoted Percentage Quoted Rate in Figures and Words (Iteration 0)
1.00 ANIL KUMAR BINDAL(GSTN-09AEEPB5231NIZI) 2500000.000 -19.200 2020000.000 Twenty Lakh Twenty Thousand
2.00 SHRI BALAJI MEDICAL STORE(GSTN-09ABEPU6629C2ZF) 2500000.000 -27.500 1812500.000 Eighteen Lakh Tweleve Thousand Five Hundred
Lowest Amount Quoted BY: SHRI BALAJI MEDICAL STORE(1812500.000)
BOQ Summary Details Tender Title: DRUG CONSUMABLE Tender ID: 2023_DGMH_809313_2
Sheet Name Sl.No Bidder Name Amount Bid Rank
BoQ1 1 SHRI BALAJI MEDICAL STORE 1812500.000 L1
2 ANIL KUMAR BINDAL 2020000.000 L2
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .